TrialThe Journal of infectious diseases2014

Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficile.

David W Eyre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.